HopeStage
Back to all studies
CompletedNCT00305578

Memantine or placebo added to lamotrigine for depression in bipolarity

About this title

Memantine Augmentation of Lamotrigine Incomplete-Response in Bipolar Depression

Read the official source — NCT00305578
Medication studyAges 18–65United States
The study in practice

Understand this study

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Listed locations
IndianapolisSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateAugust 2005
Recruitment status
Completed
Enrollment listed in the registry
29
Sponsor
Indiana University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT00305578
Official title
Show the full official title

Memantine Augmentation of Lamotrigine Incomplete Response in Bipolar Depression: A Randomized Placebo Controlled Clinical Trial

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Indianapolis

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Indiana University, a university.

Did this study involve medication?

Yes. The study involved medication, including Memantine and Placebo.

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies